Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study

Cardiovascular Diabetology

Volumn 14, Issue 1, 2015, Pages

  Kurajoh, Masafumi ^a   Koyama, Hidenori ^a   Kadoya, Manabu ^a   Naka, Mariko ^a   Miyoshi, Akio ^a   Kanzaki, Akinori ^a   Kakutani Hatayama, Miki ^a   Okazaki, Hirokazu ^a   Shoji, Takuhito ^a   Moriwaki, Yuji ^a   Yamamoto, Tetsuya ^a   Emoto, Masanori ^b   Inaba, Masaaki ^b   Namba, Mitsuyoshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac autonomic dysfunction; Heart rate variability; Leptin; Type 2 diabetes; Visceral fat accumulation

Indexed keywords

HEMOGLOBIN A1C; LEPTIN; LEPTIN RECEPTOR; BIOLOGICAL MARKER; LEPTIN RECEPTOR, HUMAN;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD SAMPLING; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; AGED; AUTONOMIC NERVOUS SYSTEM; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEART; HEART DISEASES; HEART RATE; INNERVATION; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR; UPREGULATION;

ADIPOSITY; AGED; AUTONOMIC NERVOUS SYSTEM; BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEART; HEART DISEASES; HEART RATE; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RECEPTORS, LEPTIN; RISK FACTORS; UP-REGULATION;

EID: 84940736163     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0280-6     Document Type: Article

References (46)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8 .
2. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994;107(2):239-46.
3. Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care. 2007;30(9):2392-4. doi: 10.2337/dc07-0218 .
4. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA. Body fat and the activity of the autonomic nervous system. N Engl J Med. 1988;318(17):1077-83. doi: 10.1056/NEJM198804283181701 .
5. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94(11):2850-5.
6. Liao D, Cai J, Rosamond WD, Barnes RW, Hutchinson RG, Whitsel EA, et al. Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1997;145(8):696-706.
7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-32. doi: 10.1038/372425a0 .
8. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763-70. doi: 10.1038/27376 .
9. Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, et al. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care. 1997;20(9):1476-81.
10. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Mohieldin M, Al-Katari M, Jones AF, et al. Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis. Cardiovasc Diabetol. 2007;6:18. doi: 10.1186/1475-2840-6-18 .
11. Nishimura R, Sano H, Matsudaira T, Morimoto A, Miyashita Y, Shirasawa T, et al. Changes in body mass index, leptin and adiponectin in Japanese children during a three-year follow-up period: a population-based cohort study. Cardiovasc Diabetol. 2009;8:30. doi: 10.1186/1475-2840-8-30 .
12. Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404-16. doi: 10.1016/j.cell.2014.10.058 .
13. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Eur Heart J. 1996;17(3):354-81.
14. Katz A, Liberty IF, Porath A, Ovsyshcher I, Prystowsky EN. A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J. 1999;138(1 Pt 1):32-8.
15. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001;24(2):339-43.
16. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26(6):1895-901.
17. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-97. doi: 10.1161/CIRCULATIONAHA.106.634949 .
18. Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia. 1999;42(1):68-75.
19. Karjalainen JJ, Kiviniemi AM, Hautala AJ, Piira OP, Lepojarvi ES, Peltola MA, et al. Determinants and prognostic value of cardiovascular autonomic function in coronary artery disease patients with and without type 2 diabetes. Diabetes Care. 2014;37(1):286-94. doi: 10.2337/dc13-1072 .
20. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325-9. doi: 10.1038/nature11260 .
21. Kadoya M, Koyama H, Kurajoh M, Kanzaki A, Kakutani-Hatayama M, Okazaki H, et al. Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study. Atherosclerosis. 2015;238(2):409-14. doi: 10.1016/j.atherosclerosis.2014.12.032 .
22. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93. doi: 10.2337/dc10-1303 .
23. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034 .
24. Kadoya M, Koyama H, Kanzaki A, Kurajoh M, Hatayama M, Shiraishi J, et al. Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors. PLoS One. 2014;9(8):e105977.
25. Morioka T, Emoto M, Yamazaki Y, Kawano N, Imamura S, Numaguchi R, et al. Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes. Cardiovasc Diabetol. 2014;13:10. doi: 10.1186/1475-2840-13-10 .
26. Sugisawa N, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer. 2012;15(2):206-12. doi: 10.1007/s10120-011-0099-0 .
27. Abu-Farha M, Behbehani K, Elkum N. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs. Cardiovasc Diabetol. 2014;13:76. doi: 10.1186/1475-2840-13-76 .
28. Vinagre I, Sanchez-Quesada JL, Sanchez-Hernandez J, Santos D, Ordonez-Llanos J, De Leiva A, et al. Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of LDL subfraction phenotype. Cardiovasc Diabetol. 2014;13:34. doi: 10.1186/1475-2840-13-34 .
29. Soliman AT, Omar M, Assem HM, Nasr IS, Rizk MM, El Matary W, et al. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metabolism. 2002;51(3):292-6.
30. Tatti P, Masselli L, Buonanno A, Di Mauro P, Strollo F. Leptin levels in diabetic and nondiabetic subjects. Endocrine. 2001;15(3):305-8. doi: 10.1385/ENDO:15:3:305 .
31. Garcia-Serrano S, Gutierrez-Repiso C, Gonzalo M, Garcia-Arnes J, Valdes S, Soriguer F, et al. C-peptide modifies leptin and visfatin secretion in human adipose tissue. Obesity (Silver Spring). 2015;23(8):1607-15. doi: 10.1002/oby.21137 .
32. Paolisso G, Manzella D, Montano N, Gambardella A, Varricchio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab. 2000;85(5):1810-4. doi: 10.1210/jcem.85.5.6511 .
33. Charles LE, Burchfiel CM, Sarkisian K, Li S, Miller DB, Gu JK, et al. Leptin, adiponectin, and heart rate variability among police officers. Am J Hum Biol. 2015;27(2):184-91. doi: 10.1002/ajhb.22636 .
34. Pieterse C, Schutte R, Schutte AE. Autonomic activity and leptin in Africans and whites: the SABPA study. J Hypertens. 2014;32(4):826-33. doi: 10.1097/HJH.0000000000000110 .
35. Piestrzeniewicz K, Luczak K, Lelonek M, Wranicz JK, Goch JH. Obesity and heart rate variability in men with myocardial infarction. Cardiol J. 2008;15(1):43-9.
36. Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res. 2012;2012:878760. doi: 10.1155/2012/878760 .
37. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480-4. doi: 10.1038/35078085 .
38. Vong L, Ye C, Yang Z, Choi B, Chua S Jr, Lowell BB. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron. 2011;71(1):142-54. doi: 10.1016/j.neuron.2011.05.028 .
39. Lee DK, Jeong JH, Chun SK, Chua S Jr, Jo YH. Interplay between glucose and leptin signalling determines the strength of GABAergic synapses at POMC neurons. Nat Commun. 2015;6:6618. doi: 10.1038/ncomms7618 .
40. Matsuda M, Kawasaki F, Inoue H, Kanda Y, Yamada K, Harada Y, et al. Possible contribution of adipocytokines on diabetic neuropathy. Diabetes Res Clin Pract. 2004;66(Suppl 1):S121-3. doi: 10.1016/j.diabres.2004.05.010 .
41. Sari R, Balci MK, Apaydin C. The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus. Metab Syndr Relat Disord. 2010;8(6):499-503. doi: 10.1089/met.2009.0127 .
42. Ziegler D, Voss A, Rathmann W, Strom A, Perz S, Roden M, et al. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey. Diabetologia. 2015;58(5):1118-28. doi: 10.1007/s00125-015-3534-7 .
43. Huikuri HV, Ylitalo A, Pikkujamsa SM, Ikaheimo MJ, Airaksinen KE, Rantala AO, et al. Heart rate variability in systemic hypertension. Am J Cardiol. 1996;77(12):1073-7.
44. Mylonopoulou M, Tentolouris N, Antonopoulos S, Mikros S, Katsaros K, Melidonis A, et al. Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transplant. 2010;25(11):3749-54. doi: 10.1093/ndt/gfq226 .
45. Poliakova N, Despres JP, Bergeron J, Almeras N, Tremblay A, Poirier P. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men. Metabolism. 2012;61(9):1270-9. doi: 10.1016/j.metabol.2012.02.006 .
46. Ryan C, Hollenberg M, Harvey DB, Gwynn R. Impaired parasympathetic responses in patients after myocardial infarction. Am J Cardiol. 1976;37(7):1013-8.